JP Stock MarketDetailed Quotes

4572 Carna Biosciences

Watchlist
  • 302
  • -9-2.89%
20min DelayNot Open Dec 16 15:30 JST
5.77BMarket Cap-4.40P/E (Static)

Carna Biosciences Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2023
(FY)Dec 31, 2022
(FY)Dec 31, 2021
(FY)Dec 31, 2020
(FY)Dec 31, 2019
(FY)Dec 31, 2018
(FY)Dec 31, 2017
(FY)Dec 31, 2016
(FY)Dec 31, 2015
(FY)Dec 31, 2014
Operating cash flow (Indirect Method)
Cash from operating activities
-138.56%-1.64B
56.52%-687.84M
-41.24%-1.58B
-175.10%-1.12B
233.93%1.49B
-96.66%-1.11B
-37.70%-566.3M
-203.52%-411.25M
179.57%397.28M
-87.61%-499.26M
Net profit before non-cash adjustment
14.55%-1.13B
-148.53%-1.32B
51.70%-532.5M
-220.75%-1.1B
175.66%913.06M
-64.55%-1.21B
-153.83%-733.38M
-159.44%-288.93M
157.54%486.09M
-202.81%-844.84M
Total adjustment of non-cash items
1.47%112.81M
43.28%111.18M
5.99%77.6M
-53.50%73.22M
111.50%157.47M
11.22%74.45M
137.97%66.94M
-459.71%-176.27M
-81.15%49M
815.54%260.01M
-Depreciation and amortization
5.34%35.61M
76.41%33.81M
54.42%19.16M
32.11%12.41M
-26.12%9.39M
4.97%12.72M
-44.43%12.11M
13.43%21.8M
-71.54%19.22M
79.62%67.52M
-Reversal of impairment losses recognized in profit and loss
-89.77%4.56M
368.90%44.58M
-63.97%9.51M
-40.16%26.39M
-7.30%44.1M
117.40%47.58M
-15.21%21.88M
206.36%25.81M
-96.45%8.43M
9,868.88%237.66M
-Disposal profit
-3.65%-426K
-3.01%-411K
-2.57%-399K
-2.64%-389K
-3.27%-379K
-2.51%-367K
99.80%-358K
---177.54M
--0
--0
-Net exchange gains and losses
72.21%-5.47M
-96.13%-19.67M
-522.81%-10.03M
247.29%2.37M
-54.25%683K
5.59%1.49M
-88.46%1.41M
4,557.03%12.25M
103.19%263K
13.70%-8.25M
-Remuneration paid in stock
-19.11%40.24M
-7.32%49.75M
-6.69%53.67M
37.25%57.52M
80.91%41.91M
--23.17M
----
----
----
----
-Other non-cash items
1,123.71%38.29M
-44.92%3.13M
122.65%5.68M
-140.62%-25.09M
709.59%61.76M
-131.77%-10.13M
154.42%31.88M
-377.71%-58.59M
157.15%21.1M
-1,731.15%-36.92M
Changes in working capital
-218.78%-622.86M
146.52%524.38M
-1,140.22%-1.13B
-121.59%-90.89M
2,156.03%421.07M
-81.36%18.66M
85.63%100.14M
139.14%53.95M
-261.07%-137.82M
651.38%85.56M
-Change in receivables
-156.08%-599.72M
196.34%1.07B
-7,857.13%-1.11B
52.12%-13.95M
-871.23%-29.14M
-87.21%3.78M
-56.86%29.53M
171.29%68.46M
-436.02%-96.03M
200.27%28.58M
-Change in inventory
-168.64%-21.61M
-34.83%-8.04M
-16.82%-5.97M
-144.93%-5.11M
58.17%11.37M
83.08%7.19M
-3.30%3.93M
166.60%4.06M
-2,034.92%-6.1M
117.88%315K
-Change in prepaid assets
115.28%43.58M
-76,557.91%-285.19M
--373K
----
----
----
----
----
----
----
-Change in payables
39.16%-45.11M
-271.82%-74.16M
-128.66%-19.94M
-45.69%69.59M
1,564.04%128.13M
-88.45%7.7M
459.07%66.69M
47.97%-18.57M
-162.98%-35.69M
284.31%56.67M
-Changes in other current assets
--0
-2,209.53%-177.71M
105.96%8.42M
-145.52%-141.42M
--310.71M
----
----
----
----
----
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities)
34.38%-3.37M
-25.16%-5.13M
42.45%-4.1M
13.29%-7.12M
23.55%-8.21M
-56.27%-10.74M
-18.30%-6.87M
-147.82%-5.81M
-2.72%-2.34M
-6.54%-2.28M
Interest received (cash flow from operating activities)
15.65%170K
37.38%147K
-13.71%107K
-64.67%124K
2,093.75%351K
-60.00%16K
-78.14%40K
18.06%183K
-39.69%155K
25.98%257K
Tax refund paid
-80.13%-33.38M
-145.26%-18.53M
130.14%40.94M
-2,178.83%-135.82M
-46.51%-5.96M
-134.40%-4.07M
127.25%11.82M
-1,930.42%-43.39M
43.79%-2.14M
-66.97%-3.8M
Other operating cash inflow (outflow)
0
-65.40%2.96M
327.51%8.55M
200,000.00%2M
-100.22%-1K
78.40%446K
-96.58%250K
-16.01%7.3M
-75.93%8.69M
54.97%36.11M
Operating cash flow
-136.80%-1.68B
53.90%-708.39M
-21.86%-1.54B
-185.33%-1.26B
231.01%1.48B
-101.05%-1.13B
-23.86%-561.06M
-212.78%-452.97M
185.64%401.65M
-89.84%-468.98M
Investing cash flow
Net PPE purchase and sale
90.84%-11.53M
-203.05%-125.83M
35.86%-41.52M
-58.71%-64.74M
30.05%-40.79M
-53.41%-58.31M
-22.35%-38.01M
-1,022.47%-31.07M
93.25%-2.77M
-436.31%-40.99M
Net intangibles purchase and sale
--0
-9.68%-170K
96.24%-155K
-2,556.13%-4.12M
---155K
----
---117K
--0
73.18%-232K
---865K
Net investment product transactions
----
----
----
----
----
----
----
--281.88M
----
----
Net changes in other investments
-49.51%154K
--305K
----
---1.58M
----
----
99.96%-1K
---2.8M
----
2,500.00%24K
Investing cash flow
90.95%-11.38M
-201.60%-125.7M
40.83%-41.68M
-72.02%-70.43M
29.79%-40.95M
-52.93%-58.31M
-115.38%-38.13M
8,366.80%248M
92.83%-3M
-387.71%-41.83M
Financing cash flow
Net issuance payments of debt
36.53%-152.02M
-317.60%-239.53M
136.81%110.08M
-809.22%-299M
-32.46%42.16M
184.78%62.42M
-115.29%-73.63M
812.92%481.48M
159.27%52.74M
218.14%20.34M
Net common stock issuance
123.58%1.34B
-36.71%600.82M
-7.25%949.27M
-50.60%1.02B
231.41%2.07B
72.87%625.13M
32.26%361.61M
-49.73%273.41M
1,076.53%543.93M
-92.81%46.23M
Net other fund-raising expenses
-262.80%-9.29M
1.15%5.71M
--5.64M
----
28,128.57%7.85M
-100.36%-28K
783,000.00%7.83M
-99.98%1K
--6.27M
----
Financing cash flow
222.07%1.18B
-65.54%367.01M
47.01%1.06B
-65.86%724.42M
208.61%2.12B
132.42%687.52M
-60.81%295.81M
25.20%754.9M
805.67%602.94M
-90.50%66.57M
Net cash flow
Beginning cash position
-11.49%3.38B
-11.20%3.82B
-12.53%4.3B
262.67%4.92B
-26.99%1.36B
-14.11%1.86B
33.00%2.16B
159.27%1.62B
-41.29%626.74M
74.44%1.07B
Current changes in cash
-8.51%-506.81M
9.00%-467.08M
15.43%-513.3M
-117.06%-606.98M
813.40%3.56B
-64.42%-498.82M
-155.17%-303.37M
-45.09%549.93M
325.47%1B
-199.71%-444.23M
Effect of exchange rate changes
-40.39%16.87M
-11.57%28.29M
458.24%31.99M
-829.66%-8.93M
157.09%1.22M
-34.42%-2.14M
88.35%-1.6M
-304.40%-13.69M
-199.56%-3.39M
-66.21%3.4M
Cash adjustments other than cash changes
0.00%1K
--1K
----
-150.00%-1K
200.00%2K
-100.00%-2K
---1K
----
--1K
----
End cash Position
-14.50%2.89B
-11.49%3.38B
-11.20%3.82B
-12.53%4.3B
262.67%4.92B
-26.99%1.36B
-14.11%1.86B
33.00%2.16B
159.27%1.62B
-41.29%626.74M
Free cash flow
-102.42%-1.69B
47.13%-834.39M
-18.68%-1.58B
-192.62%-1.33B
221.02%1.44B
-97.99%-1.19B
-23.79%-599.19M
-221.42%-484.04M
178.04%398.65M
-100.58%-510.83M
Currency Unit
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
JPY
Accounting Standards
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
NonUS-GAAP
(FY)Dec 31, 2023(FY)Dec 31, 2022(FY)Dec 31, 2021(FY)Dec 31, 2020(FY)Dec 31, 2019(FY)Dec 31, 2018(FY)Dec 31, 2017(FY)Dec 31, 2016(FY)Dec 31, 2015(FY)Dec 31, 2014
Operating cash flow (Indirect Method)
Cash from operating activities -138.56%-1.64B56.52%-687.84M-41.24%-1.58B-175.10%-1.12B233.93%1.49B-96.66%-1.11B-37.70%-566.3M-203.52%-411.25M179.57%397.28M-87.61%-499.26M
Net profit before non-cash adjustment 14.55%-1.13B-148.53%-1.32B51.70%-532.5M-220.75%-1.1B175.66%913.06M-64.55%-1.21B-153.83%-733.38M-159.44%-288.93M157.54%486.09M-202.81%-844.84M
Total adjustment of non-cash items 1.47%112.81M43.28%111.18M5.99%77.6M-53.50%73.22M111.50%157.47M11.22%74.45M137.97%66.94M-459.71%-176.27M-81.15%49M815.54%260.01M
-Depreciation and amortization 5.34%35.61M76.41%33.81M54.42%19.16M32.11%12.41M-26.12%9.39M4.97%12.72M-44.43%12.11M13.43%21.8M-71.54%19.22M79.62%67.52M
-Reversal of impairment losses recognized in profit and loss -89.77%4.56M368.90%44.58M-63.97%9.51M-40.16%26.39M-7.30%44.1M117.40%47.58M-15.21%21.88M206.36%25.81M-96.45%8.43M9,868.88%237.66M
-Disposal profit -3.65%-426K-3.01%-411K-2.57%-399K-2.64%-389K-3.27%-379K-2.51%-367K99.80%-358K---177.54M--0--0
-Net exchange gains and losses 72.21%-5.47M-96.13%-19.67M-522.81%-10.03M247.29%2.37M-54.25%683K5.59%1.49M-88.46%1.41M4,557.03%12.25M103.19%263K13.70%-8.25M
-Remuneration paid in stock -19.11%40.24M-7.32%49.75M-6.69%53.67M37.25%57.52M80.91%41.91M--23.17M----------------
-Other non-cash items 1,123.71%38.29M-44.92%3.13M122.65%5.68M-140.62%-25.09M709.59%61.76M-131.77%-10.13M154.42%31.88M-377.71%-58.59M157.15%21.1M-1,731.15%-36.92M
Changes in working capital -218.78%-622.86M146.52%524.38M-1,140.22%-1.13B-121.59%-90.89M2,156.03%421.07M-81.36%18.66M85.63%100.14M139.14%53.95M-261.07%-137.82M651.38%85.56M
-Change in receivables -156.08%-599.72M196.34%1.07B-7,857.13%-1.11B52.12%-13.95M-871.23%-29.14M-87.21%3.78M-56.86%29.53M171.29%68.46M-436.02%-96.03M200.27%28.58M
-Change in inventory -168.64%-21.61M-34.83%-8.04M-16.82%-5.97M-144.93%-5.11M58.17%11.37M83.08%7.19M-3.30%3.93M166.60%4.06M-2,034.92%-6.1M117.88%315K
-Change in prepaid assets 115.28%43.58M-76,557.91%-285.19M--373K----------------------------
-Change in payables 39.16%-45.11M-271.82%-74.16M-128.66%-19.94M-45.69%69.59M1,564.04%128.13M-88.45%7.7M459.07%66.69M47.97%-18.57M-162.98%-35.69M284.31%56.67M
-Changes in other current assets --0-2,209.53%-177.71M105.96%8.42M-145.52%-141.42M--310.71M--------------------
Dividends paid (cash flow from operating activities)
Dividends received (cash flow from operating activities)
Interest paid (cash flow from operating activities) 34.38%-3.37M-25.16%-5.13M42.45%-4.1M13.29%-7.12M23.55%-8.21M-56.27%-10.74M-18.30%-6.87M-147.82%-5.81M-2.72%-2.34M-6.54%-2.28M
Interest received (cash flow from operating activities) 15.65%170K37.38%147K-13.71%107K-64.67%124K2,093.75%351K-60.00%16K-78.14%40K18.06%183K-39.69%155K25.98%257K
Tax refund paid -80.13%-33.38M-145.26%-18.53M130.14%40.94M-2,178.83%-135.82M-46.51%-5.96M-134.40%-4.07M127.25%11.82M-1,930.42%-43.39M43.79%-2.14M-66.97%-3.8M
Other operating cash inflow (outflow) 0-65.40%2.96M327.51%8.55M200,000.00%2M-100.22%-1K78.40%446K-96.58%250K-16.01%7.3M-75.93%8.69M54.97%36.11M
Operating cash flow -136.80%-1.68B53.90%-708.39M-21.86%-1.54B-185.33%-1.26B231.01%1.48B-101.05%-1.13B-23.86%-561.06M-212.78%-452.97M185.64%401.65M-89.84%-468.98M
Investing cash flow
Net PPE purchase and sale 90.84%-11.53M-203.05%-125.83M35.86%-41.52M-58.71%-64.74M30.05%-40.79M-53.41%-58.31M-22.35%-38.01M-1,022.47%-31.07M93.25%-2.77M-436.31%-40.99M
Net intangibles purchase and sale --0-9.68%-170K96.24%-155K-2,556.13%-4.12M---155K-------117K--073.18%-232K---865K
Net investment product transactions ------------------------------281.88M--------
Net changes in other investments -49.51%154K--305K-------1.58M--------99.96%-1K---2.8M----2,500.00%24K
Investing cash flow 90.95%-11.38M-201.60%-125.7M40.83%-41.68M-72.02%-70.43M29.79%-40.95M-52.93%-58.31M-115.38%-38.13M8,366.80%248M92.83%-3M-387.71%-41.83M
Financing cash flow
Net issuance payments of debt 36.53%-152.02M-317.60%-239.53M136.81%110.08M-809.22%-299M-32.46%42.16M184.78%62.42M-115.29%-73.63M812.92%481.48M159.27%52.74M218.14%20.34M
Net common stock issuance 123.58%1.34B-36.71%600.82M-7.25%949.27M-50.60%1.02B231.41%2.07B72.87%625.13M32.26%361.61M-49.73%273.41M1,076.53%543.93M-92.81%46.23M
Net other fund-raising expenses -262.80%-9.29M1.15%5.71M--5.64M----28,128.57%7.85M-100.36%-28K783,000.00%7.83M-99.98%1K--6.27M----
Financing cash flow 222.07%1.18B-65.54%367.01M47.01%1.06B-65.86%724.42M208.61%2.12B132.42%687.52M-60.81%295.81M25.20%754.9M805.67%602.94M-90.50%66.57M
Net cash flow
Beginning cash position -11.49%3.38B-11.20%3.82B-12.53%4.3B262.67%4.92B-26.99%1.36B-14.11%1.86B33.00%2.16B159.27%1.62B-41.29%626.74M74.44%1.07B
Current changes in cash -8.51%-506.81M9.00%-467.08M15.43%-513.3M-117.06%-606.98M813.40%3.56B-64.42%-498.82M-155.17%-303.37M-45.09%549.93M325.47%1B-199.71%-444.23M
Effect of exchange rate changes -40.39%16.87M-11.57%28.29M458.24%31.99M-829.66%-8.93M157.09%1.22M-34.42%-2.14M88.35%-1.6M-304.40%-13.69M-199.56%-3.39M-66.21%3.4M
Cash adjustments other than cash changes 0.00%1K--1K-----150.00%-1K200.00%2K-100.00%-2K---1K------1K----
End cash Position -14.50%2.89B-11.49%3.38B-11.20%3.82B-12.53%4.3B262.67%4.92B-26.99%1.36B-14.11%1.86B33.00%2.16B159.27%1.62B-41.29%626.74M
Free cash flow -102.42%-1.69B47.13%-834.39M-18.68%-1.58B-192.62%-1.33B221.02%1.44B-97.99%-1.19B-23.79%-599.19M-221.42%-484.04M178.04%398.65M-100.58%-510.83M
Currency Unit JPYJPYJPYJPYJPYJPYJPYJPYJPYJPY
Accounting Standards NonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAPNonUS-GAAP
Top JP Stock Gainers
Symbol Price % Chg
Wintest
6721
110 +37.50%
Osaka Yuka Industry
4124
1920 +26.32%
D. Western Therapeutics Institute
4576
130 +25.00%
Asiro
7378
1551 +23.98%
Hamee
3134
1293 +23.85%

See the daily top gainer.